Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Thoracic 1Other 1

Conditions

Carcinoma, Non-Small-Cell Lung 11Lung Neoplasms 4Carcinoma, Medullary 4Breast Neoplasms 4Thyroid Neoplasms 3Thyroid Cancer, Papillary 3Colonic Neoplasms 3Thyroid Diseases 2Thoracic Neoplasms 2Respiratory Tract Neoplasms 2Respiratory Tract Diseases 2Neoplasms by Site 2Neoplasms 2Lung Diseases 2Head and Neck Neoplasms 2Endocrine System Diseases 2Endocrine Gland Neoplasms 2Central Nervous System Neoplasms 2Carcinoma, Bronchogenic 2Bronchial Neoplasms 2Sexual Dysfunction, Physiological 1Sarcoma 1Pancreatic Neoplasms 1Myofibromatosis 1Gastrointestinal Neoplasms 1Eunuchism 1Erectile Dysfunction 1

Interventions

trametinib 1sotorasib 1selpercatinib 1pembrolizumab 1osimertinib 1lorlatinib 1dabrafenib 1cemiplimab 1brigatinib 1alectinib 1Pemetrexed 1Paclitaxel 1Nivolumab 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Erectile Dysfunction × selpercatinib × Thoracic × Clear all
NCT06532149 2024-08-09

EROS

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Recruiting
80 enrolled
OtherThoracic

Carcinoma, Non-Small-Cell Lung, Eunuchism, Erectile Dysfunction, Sexual Dysfunction, Physiological

Data powered by HemOnc (CC BY 4.0) Colophon âš¡